Zobrazeno 1 - 10
of 579
pro vyhledávání: '"Rohrlich, Ps"'
Autor:
Thalhammer J; Centre Leon Berard, France., Jeziorski E; University Hospital of Montpellier, Montpellier, France., Marec-Berard P; Institut d'Hématologie et Oncologie Pédiatrique (IHOPe)., Barkaoui MA; French Reference Center for Langerhans Cell Histiocytosis, Trousseau Hospital, Paris, France., Pagnier A; Centre Hospitalo-Universitaire de Grenoble, Grenoble Cedex 9, France., Rohrlich PS; CHU Nice, Nice, France., Chevallier A; Hopital Trousseau, Paris, France., Carausu L; CHRU Brest, Brest, France., Aladjidi N; Bordeaux University Hospital / CEREVANCE, BORDEAUX, France., Rigaud C; Gustave Roussy Cancer Campus, Villejuif, France., Leruste A; Institut Curie, Paris, France., Azarnoush S; Hôpital Robert Debré, AP-HP, Université de Paris, Paris, France, Paris, France., Lauvray T; Centre Hospitalo-Universitaire de Limoges, Limoges, France., Le Louet S; French Reference Center for Langerhans Cell Histiocytosis, Paris, France., Gandemer V; Department of Pediatric Hematology and Oncology CHU Hopital Sud, Rennes, France., Treguier P; Department of Pediatric Hematology and Oncology CHU Hopital Sud, Rennes, France., Mansuy L; Centre Hospitalo-Universitaire de Nancy, NANCY, France., Pasquet M; Hopital Purpan, CHU Toulouse, Toulouse, France., Olivier L; Hopital Purpan, CHU Toulouse, Toulouse, France., Rome A; La Timone University Hospital of Marseille, APHM, Marseille, France., Saultier P; La Timone University Hospital of Marseille, APHM, Department of Pediatric Oncology, Marseille, France., Isfan F; La Timone University Hospital of Marseille, APHM, Department of Pediatric Oncology, Marseille, France., Renard C; Institut d'hématologie et d'oncologie pédiatrique, Hospices Civils de Lyon, LYON, France., Li Thiao Te V; CHU AMIENS, Amiens, France., Salmon A; CHRU STRASBOURG, STRASBOURG, France., Blanc L; Centre Hospitalier Universitaire de Poitiers, Poitiers, France., Abou Chahla W; Centre Leon Berard, France., Lambilliotte A; CHRU de Lille France, Lille, France., Stephan JL; University of Saint Etienne, Saint Etienne, France., Geissmann F; Memorial Sloan Kettering Cancer Center, NY, New York, United States., Lejeune J; Tours university hospital, Tours, France., Mallebranche C; Université d'Angers, Université de Nantes, Inserm, CNRS, CRCI2NA, SFR ICAT, Angers, France; CHU Angers, Pediatric immuno-hemato-oncology Unit, Angers, France, Angers, France., Reguerre Y; HOPITAL FELIX GUYON LA REUNION, saint denis, France., Grain A; Nantes University Hospital, Nantes, France., Thomas C; Nantes University Hospital, Nantes, France., Hélias-Rodzewicz Z; Nantes University Hospital, Nantes, France., Moshous D; Hôpital Necker-Enfants Malades, Paris, France., Fenneteau O; Hôpital Robert Debré APHP, PARIS, France., Coulomb-L'hermine A; Sorbonne Université - Trousseau Hospital, Paris, France., Lapillonne H; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, AP-HP Hôpital Trousseau, Paris, France, France., de Saint Basile G; Hopital Necker-Enfants Malades, Paris, France., Emile JF; Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Smart Imaging, Service de Pathologie, Boulogne, France., Héritier S; French Reference Center for Langerhans Cell Histiocytosis, PARIS, France., Donadieu J; Hopital Trousseau, Paris, France.
Publikováno v:
Blood [Blood] 2024 Nov 01. Date of Electronic Publication: 2024 Nov 01.
Autor:
Strullu M; Pediatric Hematology and Immunology Department, Robert-Debré Hospital (Assistance Publique-Hôpitaux de Paris (APHP)), Paris, France.; University of Paris Cité, Paris, France.; INSERM U1131, IUH, Paris, France., Caye-Eude A; Genetic Department, Robert-Debré Hospital, APHP, Paris, France., Robert E; INSERM U1170, Gustave Roussy Cancer Campus, Université Paris Saclay, PEDIAC Program, Villejuif, France., Renard JM; Hematology Laboratory, Robert-Debré Hospital, APHP, Paris, France., Chaye A; Hematology Laboratory, Robert-Debré Hospital, APHP, Paris, France., Galimand J; Genetic Department, Armand Trousseau, APHP, Paris, France., Fenneteau O; Hematology Laboratory, Robert-Debré Hospital, APHP, Paris, France., Arfeuille C; INSERM U1131, IUH, Paris, France.; Genetic Department, Robert-Debré Hospital, APHP, Paris, France., Cuccuini W; Hematology Laboratory, Saint-Louis Hospital, APHP, Paris, France., Theron A; Department of Pediatric Oncology and Hematology, CHU Montpellier, Montpellier, France., Thouvenin S; Department of Pediatric Onco-hematology, CHU de Saint-Etienne, Saint-Etienne, France., Paillard C; Department of Pediatric Hematology-Oncology, CHU de Strasbourg, Strasbourg, France., Petit A; Department of Pediatric Onco-hematology, Sorbonne University, Armand Trousseau Hospital, APHP, Paris, France., Rohrlich PS; Pediatric Hematology-Oncology Department, CHU de Nice, Université de Côte d'Azur, Nice, France., Cavé H; University of Paris Cité, Paris, France.; INSERM U1131, IUH, Paris, France.; Genetic Department, Robert-Debré Hospital, APHP, Paris, France., Baruchel A; Pediatric Hematology and Immunology Department, Robert-Debré Hospital (Assistance Publique-Hôpitaux de Paris (APHP)), Paris, France.; University of Paris Cité, Paris, France.; URP-3518, Institut de Recherche Saint-Louis, Paris, France., Lainey E; University of Paris Cité, Paris, France. elodie.lainey@aphp.fr.; INSERM U1131, IUH, Paris, France. elodie.lainey@aphp.fr.; Hematology Laboratory, Robert-Debré Hospital, APHP, Paris, France. elodie.lainey@aphp.fr.
Publikováno v:
Leukemia [Leukemia] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Peyre M; Hematology Department, Saint-Antoine Hospital, APHP, Paris, France., Sicre de Fontbrune F; Hematology Transplant Unit - French Reference Center for Aplastic Anemia, Saint Louis Hospital, APHP, Paris, France. Flore.sicre-de-fontbrune@aphp.fr., Berceanu A; Hematology Department, Besançon University Hospital, Besançon, France., Benjemia L; Hematology Department, Besançon University Hospital, Besançon, France., Castelle M; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital, APHP, Paris, France., D'Aveni M; Hematology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France., Marçais A; Hematology Department, Necker Hospital, APHP, Paris, France., Kaphan E; Hematology Department, Grenoble University Hospital, Grenoble, France., Bulabois CE; Hematology Department, Grenoble University Hospital, Grenoble, France., Sirvent A; Hematology Department, Montpellier University Hospital, Montpellier, France., Rohrlich PS; Nice University Hospital, Nice, France., Coiteux V; Hematology Department, Lille University Hospital, Lille, France., Chantepie S; Hematology Department, Caen University Hospital, Caen, France., Nguyen-Quoc S; Hematology Department, Pitié-Salpêtrière Hospital, APHP, Paris, France., Peffault de Latour R; Hematology Transplant Unit - French Reference Center for Aplastic Anemia, Saint Louis Hospital, APHP, Paris, France., Coppo P; Hematology Department, Saint-Antoine Hospital, APHP, Paris, France. paul.coppo@aphp.fr.; French Reference Center for Thrombotic Microangiopathies, Paris, France. paul.coppo@aphp.fr.; INSERM UMRS1138, Centre de Recherche des Cordeliers, Paris, France. paul.coppo@aphp.fr.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2024 Jul; Vol. 59 (7), pp. 1034-1036. Date of Electronic Publication: 2024 Apr 11.
Autor:
Jourdy Y; Hospices Civils de Lyon, Groupe Hospitalier Est, Service d'hématologie biologique, Bron, France; Université Claude Bernard Lyon 1, UR4609 Hémostase et thrombose, Lyon, France. Electronic address: yohann.jourdy@chu-lyon.fr., Chatron N; Hospices Civils de Lyon, Groupe Hospitalier Est, Service de génétique, Bron, France; Université Claude Bernard Lyon 1 - CNRS UMR 5261 -INSERM U1315, Institute NeuroMyoGène, Laboratoire Physiopathologie et Génétique du Neurone et du Muscle, Lyon, France., Frétigny M; Hospices Civils de Lyon, Groupe Hospitalier Est, Service d'hématologie biologique, Bron, France., Zawadzki C; Pôle de Biologie Pathologie Génétique, Institut d'Hématologie - Transfusion, CHU Lille, Lille, France., Lienhart A; Hospices Civils de Lyon, Lyon Hemophilia Center and Clinical Haemostasis Unit, Bron, France., Stieltjes N; Haemophilia Treatment Center, Cochin Hospital, AP-HP, Paris, France., Rohrlich PS; Service d'hématologie Clinique, CHU de Nice, Nice, France., Thauvin-Robinet C; Centre de Génétique, Centre de Référence, Déficiences Intellectuelles de Causes Rares, Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France., Volot F; CRC-MHC Dijon, CHU Dijon, Dijon, France., Hamida YF; Laboratoire de recherche en hémostase, Université d'Alger 1, Alger, Algérie., Hariti G; Laboratoire de recherche en hémostase, Université d'Alger 1, Alger, Algérie., Leuci A; Université Claude Bernard Lyon 1, UR4609 Hémostase et thrombose, Lyon, France., Dargaud Y; Université Claude Bernard Lyon 1, UR4609 Hémostase et thrombose, Lyon, France; Hospices Civils de Lyon, Lyon Hemophilia Center and Clinical Haemostasis Unit, Bron, France., Sanlaville D; Hospices Civils de Lyon, Groupe Hospitalier Est, Service de génétique, Bron, France; Université Claude Bernard Lyon 1 - CNRS UMR 5261 -INSERM U1315, Institute NeuroMyoGène, Laboratoire Physiopathologie et Génétique du Neurone et du Muscle, Lyon, France., Vinciguerra C; Hospices Civils de Lyon, Groupe Hospitalier Est, Service d'hématologie biologique, Bron, France; Université Claude Bernard Lyon 1, UR4609 Hémostase et thrombose, Lyon, France.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Jun; Vol. 22 (6), pp. 1616-1626. Date of Electronic Publication: 2024 Mar 13.
Autor:
Kypraios A; Université Côte d'Azur, Inserm C3M, 06200 Nice, France.; Team#4: 'Fundamental to Translational Research on Dysregulated Hematopoiesis-DysHema', Centre Méditerranéen de Médecine Moléculaire-C3M-Inserm U1065, Bâtiment Universitaire ARCHIMED, 151 Route Saint Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France., Bennour J; Université Côte d'Azur, Inserm C3M, 06200 Nice, France.; Team#4: 'Fundamental to Translational Research on Dysregulated Hematopoiesis-DysHema', Centre Méditerranéen de Médecine Moléculaire-C3M-Inserm U1065, Bâtiment Universitaire ARCHIMED, 151 Route Saint Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France., Imbert V; Université Côte d'Azur, Inserm C3M, 06200 Nice, France.; Team#4: 'Fundamental to Translational Research on Dysregulated Hematopoiesis-DysHema', Centre Méditerranéen de Médecine Moléculaire-C3M-Inserm U1065, Bâtiment Universitaire ARCHIMED, 151 Route Saint Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France., David L; Université Côte d'Azur, Inserm C3M, 06200 Nice, France.; Team#4: 'Fundamental to Translational Research on Dysregulated Hematopoiesis-DysHema', Centre Méditerranéen de Médecine Moléculaire-C3M-Inserm U1065, Bâtiment Universitaire ARCHIMED, 151 Route Saint Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France., Calvo J; Université de Paris, Inserm, CEA, 92260 Fontenay-aux-Roses, France., Pflumio F; Université de Paris, Inserm, CEA, 92260 Fontenay-aux-Roses, France., Bonnet R; Université Côte d'Azur, Inserm C3M, 06200 Nice, France.; Team#4: 'Fundamental to Translational Research on Dysregulated Hematopoiesis-DysHema', Centre Méditerranéen de Médecine Moléculaire-C3M-Inserm U1065, Bâtiment Universitaire ARCHIMED, 151 Route Saint Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France., Couralet M; Université Côte d'Azur, CNRS, IPMC, 06560 Valbonne, France.; UCA GenomiX, IPMC, 06560 Valbonne, France., Magnone V; Université Côte d'Azur, CNRS, IPMC, 06560 Valbonne, France.; UCA GenomiX, IPMC, 06560 Valbonne, France., Lebrigand K; Université Côte d'Azur, CNRS, IPMC, 06560 Valbonne, France.; UCA GenomiX, IPMC, 06560 Valbonne, France., Barbry P; Université Côte d'Azur, Inserm C3M, 06200 Nice, France.; Team#4: 'Fundamental to Translational Research on Dysregulated Hematopoiesis-DysHema', Centre Méditerranéen de Médecine Moléculaire-C3M-Inserm U1065, Bâtiment Universitaire ARCHIMED, 151 Route Saint Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France.; CHU de Nice, Hôpital de l'Archet, 06000 Nice, France., Rohrlich PS; Université Côte d'Azur, Inserm C3M, 06200 Nice, France.; Team#4: 'Fundamental to Translational Research on Dysregulated Hematopoiesis-DysHema', Centre Méditerranéen de Médecine Moléculaire-C3M-Inserm U1065, Bâtiment Universitaire ARCHIMED, 151 Route Saint Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France.; CHU de Nice, Hôpital de l'Archet, 06000 Nice, France., Peyron JF; Université Côte d'Azur, Inserm C3M, 06200 Nice, France.; Team#4: 'Fundamental to Translational Research on Dysregulated Hematopoiesis-DysHema', Centre Méditerranéen de Médecine Moléculaire-C3M-Inserm U1065, Bâtiment Universitaire ARCHIMED, 151 Route Saint Antoine de Ginestière, BP 2 3194, CEDEX 3, 06204 Nice, France.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Apr 25; Vol. 16 (9). Date of Electronic Publication: 2024 Apr 25.
Autor:
Simonin M; Service d'hématologie et oncologie pédiatrique, hôpital Armand-Trousseau, Assistance publique des Hôpitaux de Paris (AP-HP), Sorbonne université, Paris, France., Lainey E; Laboratoire d'hématologie, Hôpital Robert-Debré, Assistance publique des Hôpitaux de Paris (AP-HP), Université Paris-Cité, Paris, France., Rialland F; Service d'onco-hématologie pédiatrique, Centre hospitalo-universitaire de Nantes, Nantes, France., Caye-Eude A; Département de génétique, UF de génétique moléculaire, Hôpital Robert-Debré, Assistance publique des Hôpitaux de Paris (AP-HP), Université Paris-Cité, Paris, France., Reguerre Y; Service d'oncologie et d'hématologie pédiatrique, Centre hospitalo-universitaire de Saint-Denis, Saint-Denis, La Réunion, France., Boutroux H; Service d'hématologie et oncologie pédiatrique, hôpital Armand-Trousseau, Assistance publique des Hôpitaux de Paris (AP-HP), Sorbonne université, Paris, France., Azarnoush S; Service d'hématologie et immunologie pédiatrique, Hôpital Robert-Debré, Assistance publique des Hôpitaux de Paris (AP-HP), Université Paris-Cité, Paris, France., Thouvenin S; Service d'oncologie et hématologie pédiatrique, Centre hospitalo-universitaire de Saint-Étienne, Saint-Étienne, France., Rohrlich PS; Service d'hématologie pédiatrique, Centre hospitalo-universitaire de Nice, Nice, France. Electronic address: rohrlich.ps@chu-nice.fr., Baruchel A; Service d'hématologie et immunologie pédiatrique, Hôpital Robert-Debré, Assistance publique des Hôpitaux de Paris (AP-HP), Université Paris-Cité, Paris, France. Electronic address: andre.baruchel@aphp.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2023 Oct 27. Date of Electronic Publication: 2023 Oct 27.
Autor:
Grain A; Pediatric Hematology-Oncology Department, CHU Hopital Mère-Enfant, Nantes, France. audrey.grain.chu@gmail.com., Rialland-Battisti F; Pediatric Hematology-Oncology Department, CHU Hopital Mère-Enfant, Nantes, France., Chevallier P; Hematology Department, CHU Hotel Dieu, Nantes, France., Blin N; Hematology Department, CHU Hotel Dieu, Nantes, France., Dalle JH; Robert Debré University Hospital (APHP), Université de Paris, Paris, France., Michel G; Department of Paediatric Haematology and Oncology and EA3279, Timone Children Hospital and Aix-Marseille University, Marseille, France., Dhédin N; AYA Unit, Clinical Hematology Departments, Saint-Louis Hospital, Paris, France., Peffault de Latour R; BMT Unit, Department of Hematology, Hospital St. Louis, Paris, France., Pochon C; Allogeneic Hematopoietic Stem Cell Transplantation Unit, Department of Pediatric Oncohematology, Nancy University Hospital, Vandœuvre-lès-Nancy, France., Yakoub-Agha I; CHU de Lille, Université de Lille, LIRIC, Inserm U995, Lille, France., Bertrand Y; Institut of Hematology and Pediatric Oncology, Hospices Civils de Lyon, Université Lyon 1, Lyon, France., Sirvent A; Department of Clinical Haematology, CHU Montpellier, Montpellier, France., Jubert C; Department of Pediatric Hematology, Bordeaux Hospital, Bordeaux, France., Forcade E; Department of Hematology and Cellular Therapy, CHU Bordeaux, Bordeaux, France., Berceanu A; Department of Hematology, CHU Besançon, Besançon, France., Gandemer V; Department of Pediatric Oncology and Haematology, University Hospital of Rennes, Rennes, France., Schneider P; Department of Pediatric Hematology and Oncology, Centre Hospitalo-Universitaire de Rouen, Rouen, France., Bay JO; Department of Hematology and Cellular Therapy CHU Estaing, CHU Clermont-Ferrand, Clermont-Ferrand, France., Rohrlich PS; Pediatric Hematology Department, CHU de Nice, Nice, France., Brissot E; Department of Haematology, Hôpital Saint-Antoine, Paris, France., Paillard C; Pediatric Oncohematology and Bone Marrow Transplantation Unit, Hôpital de Hautepierre, CHRU, Strasbourg, France., Plantaz D; Department of Pediatric Hematology-Oncology, University Hospital Grenoble, Grenoble, France., Nguyen Quoc S; Department of Hematology, La Pitié University Hospital, Paris, France., Gonzales F; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277, CANTHER, Cancer Heterogeneity Plasticity and Resistance to Therapies, 59000, Lille, France., Maillard N; Hematology Department, CHU Poitiers, Poitier, France., Planche L; Clinical Research Unit, CHD Vendée, La Roche sur Yon, France., Baruchel A; Robert Debré University Hospital (APHP), Université de Paris, Paris, France.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Apr; Vol. 149 (4), pp. 1473-1483. Date of Electronic Publication: 2022 May 04.
Autor:
Giebel, S, Labopin, M, Sobczyk-Kruszelnicka, M, Stelljes, M, Byrne, JL, Fegueux, N, Beelen, DW, Rovira, M, Spyridonidis, A, Blaise, D, Bornhauser, M, Karadogan, I, Savani, BN, Nagler, A, Mohty, M, Martin, S, Chevallier, P, Neubauer, A, Damaj, G, Koc, Y, Ganser, A, Collin, M, Yakoub-Agha, I, Ozdogu, H, Araujo, MC, Itala-Remes, M, Orchard, K, Isaksson, C, Bethge, W, Martin, H, Aljurf, M, Faber, E, Caballero, D, Zak, P, Leleu, X, Bay, JO, Rohrlich, PS, Kroger, N, Huynh, A, Schafer-Eckart, K, Milpied, N, Lenhoff, S, Ho, A, Lopez, JLB, Mordini, N, Lioure, B, Halaburda, K, Olivieri, A, Gedde-Dahl, T, Protheroe, R, Tischer, J, Klammer, M, Clausen, J, Potter, V, Ladetto, M, Tilly, H, Deconinck, E, Brecht, A, Muller, LP, Heinicke, T, Carrete, JPT, Bazarbachi, A, Remenyi, P, Rubio, MT, Fanin, R, Perez-Simon, JA, Niels, M, Diez-Martin, JL, Arat, M, Hermine, O, Socie, G, Cornelissen, JJ, Santarone, S, Guyotat, D, Bulabois, CE, Bernasconi, P, Johansson, JE, Vrhovac, R, Greinix, H, Lorenzo, JLL, Apte, S, Craddock, C, Kobbe, G, Zahrani, MA, Dreger, P, Lange, A, Tbakhi, A, Meijer, E, Llamas, CV, Santasusana, JMR, Corradini, P, Benedetti, F, Rambaldi, A, Gandemer, V, Malfuson, JV, Kaare, A, Risitano, A, Petrini, M, Selleri, C, Wu, DP
Publikováno v:
Bone Marrow Transplantation
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
The optimal conditioning for patients with acute myeloid leukemia in first complete remission treated with allogeneic hematopoietic cell transplantation (allo-HCT) has not been defined so far. In this retrospective study, we compared two "reduced-tox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3648997c04fa97d9f102964f774d16ce
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4419
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4419
Autor:
Rialland F; CHU de Nantes, Nantes, France. fanny.rialland@chu-nantes.fr., Grain A; CHU de Nantes, Nantes, France., Labopin M; Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France., Michel G; Department of Pediatric Immunology, Hematology and Oncology, Timone Enfants Hospital and Aix-Marseille University, Marseille, France., Gandemer V; University hospital of Rennes, University of Rennes1, Rennes, France., Paillard C; Department of Paediatric Haematology and Oncology, Strasbourg University Hospital, Strasbourg, France., Pochon C; Hôpital Brabois, Nancy, France., Clement L; CHU Bordeaux, Bordeaux, France., Brissot E; Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France., Jubert C; CHU Bordeaux, Bordeaux, France., Sirvent A; University Hospital, Montpellier, France., Rohrlich PS; Nice University Hospital, Nice, France., Plantaz D; University Hospital of Grenoble, La Tronche, France., Dalle JH; Hôpital Robert Debré, GH APHP Nord - Université de Paris, Paris, France., Mohty M; Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2022 Nov; Vol. 57 (11), pp. 1698-1703. Date of Electronic Publication: 2022 Aug 26.
Autor:
Machowicz R; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. r.machowicz@wp.pl., Suarez F; Service d'hématologie adultes, Hôpital Necker-Enfants Malades - AP-HP. Centre Université de Paris Institut Imagine - INSERM UMR 1163 et CNRS ERL 8254 Université de Paris, Paris, France., Wiktor-Jedrzejczak W; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland., Eikema DJ; EBMT Statistical Unit, Leiden, The Netherlands., de Wreede LC; Department of Biomedical Data Sciences, LUMC, Leiden, The Netherlands., Blok HJ; EBMT Data Office Leiden, Leiden, The Netherlands., Isaksson C; Umeå University Hospital, Umeå, Sweden., Einsele H; Universitätsklinikum Würzburg, Würzburg, Germany., Poiré X; Cliniques Universitaires St. Luc, Brussels, Belgium., van Dorp S; Radboud University - Medical Centre, Nijmegen, The Netherlands., Nikolousis E; Birmingham Heartlands Hospital, Birmingham, UK., Johansson JE; Sahlgrenska University Hospital, Goeteborg, Sweden., Kobbe G; University Hospital Düsseldorf, Medical Faculty of the Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Zecca M; Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Arnold R; Charité Universitätsmedizin Berlin, Berlin, Germany., Gerbitz A; Charité Universitätsmedizin Berlin, Berlin, Germany., Finke J; University of Freiburg, Freiburg, Germany., Díez-Martín JL; Hematology Department, Hospital General Universitario Gregorio Marañon, Instituto de Investigaciónes sanitarias Gregorio Marañon, Medicina, Universidad Complutense, Madrid, Spain., Bonifazi F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., McQuaker G; Queen Elizabeth University Hospital, Glasgow, UK., Lenhoff S; Skanes University Hospital, Lund, Sweden., Rohrlich PS; Department of Hematology, CHU de Nice, University of Cote d'Azur, Nice, France., Theobald M; University Medical Center, University Cancer Center, Department of Hematology, Medical Oncology, and Pneumology, Mainz, Germany., Ljungman P; Dept. of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden., Collin M; Freeman Hospital, Newcastle-Upon-Tyne, Newcastle upon Tyne, UK., Albert MH; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany., Ehninger G; Universitätsklinikum Dresden, Dresden, Germany., Carlson K; University Hospital, Uppsala, Sweden., Halaburda K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Lehmberg K; University Hospital Eppendorf, Hamburg, Germany., Schönland S; University of Heidelberg, Heidelberg, Germany., Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France., Gennery AR; Translational and Clinical Research Institute, Newcastle University and Dept Paediatric Immunology + HSCT, Great North Childrens' Hospital Newcastle upon Tyne, Newcastle upon Tyne, UK., Lankester AC; Willem-Alexander Children's Hospital, Paediatric Stem Cell Transplantation Program, Leiden University Medical Center, Leiden, The Netherlands., Kröger N; University Hospital Eppendorf, Hamburg, Germany.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2022 May; Vol. 57 (5), pp. 817-823. Date of Electronic Publication: 2022 Mar 24.